Neurological disorders are now the leading cause of disability worldwide, placing growing pressure on individuals, families, healthcare systems and economies.
At the same time, brain health is finally receiving the attention it deserves. Advances in diagnostics, treatments and our understanding of neurodegenerative disease are creating new opportunities to improve outcomes, while growing public and policy attention continues to create momentum for change.
Despite this progress, factors such as sex, gender, ethnicity and wider social determinants continue to shape experiences and outcomes across the neurodegenerative disease journey.
Join us on Thursday 3 September 2026 for a thought-provoking discussion exploring how inequities arise across the neurodegenerative disease journey, and what must change to deliver more equitable outcomes.
Together, we'll examine how healthcare, research, policy and communications can help ensure advances in brain health reach everyone who stands to benefit.
Speakers
- Dr Sasha Bozeat
Global Medical Science Leader, Roche
- Dr Maria Teresa Ferretti
Co-Chair, Coordinating Panel on DEI in neurology, European Academy of Neurology
- Dr Karan Jutlla
Founder and Head of the Centre for Applied and Inclusive Health Research, University of Wolverhampton
Event Details
📅 Thursday 3 September 2026
🕔 17:00–18:30
📍 Riverside House, 2A Southwark Bridge Road, London SE1 9HA
💻 Hybrid event
Brought to you by Madano, Woman in Pharma (WiP) and the Healthcare Communications Association (HCA)